MO-0556 Reduction of the CTV margin in glioblastoma leads to dosimetric benefit without compromising outcome.
Saved in:
| Title: | MO-0556 Reduction of the CTV margin in glioblastoma leads to dosimetric benefit without compromising outcome. |
|---|---|
| Authors: | Di Perri, D. (AUTHOR), Hartgerink, D. (AUTHOR), Terhaag, K. (AUTHOR), Houben, R. (AUTHOR), Compter, I. (AUTHOR), Eekers, D. (AUTHOR) |
| Source: | Radiotherapy & Oncology. 2023 Supplement 1, Vol. 182, pS435-S437. 3p. |
| Database: | Academic Search Ultimate |
| ISSN: | 01678140 |
|---|---|
| DOI: | 10.1016/S0167-8140(23)08412-8 |
